As our country struggles with the seismic economic shifts caused by the COVID-19 pandemic, regulators have eased restrictions on anti-competition regulations so businesses can work together to produce and transport essential items. But they are also closely monitoring the marketing and pricing of such products to ensure businesses don’t take advantage of the consumers who are clamoring for much-needed items.
In this webinar, we will detail the current antitrust landscape for businesses, including health care companies, that are considering cooperation agreements, and what may be allowed by the FTC and DOJ. We will provide key information on price gouging statutes, including a survey of laws from several states and an overview of false advertising actions and enforcement efforts. We will also address situations where businesses may consider using their discretion to extend expiring price promotions for consumers facing economic hardship.
You’ll come away with a better understanding of what companies can and can’t do when partnering with other businesses, adjusting pricing and marketing COVID-19-related products.
The live presentation of this webinar was approved for 1.2 hours general CLE credit in Missouri and 1.0 hour of general CLE credit in California and Illinois. CLE credit in Texas is pending. If you are interested in receiving credit for watching the recorded presentation, please click here.
April 21, 2020
Although we would like to hear from you, we cannot represent you until we know that doing so will not create a conflict of interest. Also, we cannot treat unsolicited information as confidential. Accordingly, please do not send us any information about any matter that may involve you until you receive a written statement from us that we represent you (an ‘engagement letter’).
By clicking the ‘ACCEPT’ button, you agree that we may review any information you transmit to us. You recognize that our review of your information, even if you submitted it in a good faith effort to retain us, and, further, even if you consider it confidential, does not preclude us from representing another client directly adverse to you, even in a matter where that information could and will be used against you. Please click the ‘ACCEPT’ button if you understand and accept the foregoing statement and wish to proceed.